Protein and Viral-Vector Quantification with Amperia™
Supporting fast, reliable and accessible measurement across routine workflows
Protein and viral-vector quantification supports decisions across discovery and development, frequently involving crude or variable sample matrices. The Amperia™ platform combines sensor-based, dip-and-read assays with automated Redox Electrochemical Detection (RED) to provide a practical and consistent route to quantitative measurement without the need for optics, fluidics or complex instrumentation.
A practical platform for routine quantification.
Supporting real workflows across proteins, viral vectors and tagged constructs.
Amperia™ brings together compact hardware, assay-ready sensor strips and guided software to simplify quantification across day-to-day biologics workflows. Its sensor-based, dip-and-read format avoids optics and fluidics, helping teams generate consistent results with straightforward setup.
With automated assay and ready-to-use consumables, Amperia™ provides a practical route to measuring antibodies, AAV capsids and tagged proteins — whether working with purified material or crude, variable samples.
For research use only. Not for diagnostic purposes.
Designed to support key biologics workflows:
-
Antibody therapeutics
Reliable titre measurement from early candidate screening to process optimisation. -
Protein expression & engineering
Rapid quantification of tagged proteins and expressed constructs directly from crude samples. -
Gene & cell therapy
Consistent AAV capsid measurement across development, optimisation and in-process tracking. -
Cell line development
Faster clone assessment and screening through streamlined, automated quantification. -
General discovery workflows
Practical, accessible tools that support high-quality data generation with minimal complexity.
Explore related resources.
Products:
Applications and insights:
Request details or schedule a demonstration.
Interested in learning more about the Amperia™ platform?
Complete the form and a member of the Abselion team will get in touch.